Glucagon-like peptide-1 receptor (GLP-1R) signaling ameliorates dysfunctional immunity in COPD patients
Jingwen Huang,1,* Huahua Yi,1,* Chunliu Zhao,2 Yifan Zhang,3 Liying Zhu,3 Bing Liu,1 Ping He,4 Min Zhou1 1Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 2Department of Respiratory...
Main Authors: | Huang J, Yi H, Zhao C, Zhang Y, Zhu L, Liu B, He P, Zhou M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-10-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/glucagon-like-peptide-1-receptor-glp-1r-signaling-ameliorates-dysfunct-peer-reviewed-article-COPD |
Similar Items
-
Glucagon-like peptide-1 analogues: An overview
by: Vishal Gupta
Published: (2013-01-01) -
The role of human glucagon-like peptide-1 analog in therapy of type 2 dianetes mellitus
by: Marina Vladimirovna Shestakova
Published: (2010-09-01) -
Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes
by: Fujishima Yuya, et al.
Published: (2012-09-01) -
Effects of exercise on glucagon-like peptide-1 (GLP-1)
by: Shin-ya Ueda, et al.
Published: (2013-06-01) -
Gglucagon-like peptide-1 analogue liraglutide (Saxenda®): mechanism of action, efficacy for the treatment of obesity
by: Tatiana I. Romantsova
Published: (2018-04-01)